The company said that at least one patch was found to have small crystals of the potent active ingredient.
Related Articles on Pain Management:
Convergence Pharmaceuticals Neuropatic Pain Drug Completes Phase I Trials
Trial for Boston Scientific’s Spinal Cord Stimulation Device Shows Promising Results
Oregon House Co-Speaker Visits Middle Fork Surgery Center for Pain Management Policy Discussion
